In a recent talk at the CVOT Summit, in October 2020, world-leading US cardiologist Dr Mikhail Kosiborod presented convincing data to support the CaReMe Model of Care.
Using the clinical findings from his own Clinic – Saint Luke’s Cardiometabolic Center of Excellence (CMCE) in Kansas City – Dr Kosiborod clearly demonstrated the benefits of adopting an interdisciplinary, integrated Model of Care for those living on the CaReMe risk continuum.
When assessed alongside a control group, patients at the Cardiometabolic Center of Excellence experienced a significantly greater reduction in cardiovascular disease risk factors such as LDL cholesterol, weight, systolic blood pressure and HbA1c. The use of guideline-directed medical therapies was also 20-fold higher in the group that received CaReMe treatment. CMCE patients also used significantly lower doses of insulin over time.
As Dr Kosiborod pointed out in his talk, collaborative systems of care are currently either nascent or non-existent – but it is time for a paradigm shift in the treatment of people living on the CaReMe risk continuum.
